Skip to content
Disclosery

Decheng Capital Management III (Cayman), LLC

Follow

13F filer, CIK 1747821, Grand Cayman, Cayman Islands

Decheng Capital Management III (Cayman), LLC reported $275,828,000 across 26 holdings for the quarter ended 2022-09-30, in a 13F-HR filed 2022-11-08. Its ten largest share positions make up 78.99% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-22-115855

Period
2022-09-30
Reported value
$276M
Holdings
26
Top 10 weight
78.99%
New
3
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ALPINE IMMUNE SCIENCES INCadded+2,000,000$14.4M
Pyxis Oncology, Inc (former…new+1,894,551$5.12M
SEATTLE GENETICS INCnew+23,014$3.15M
ALBIREO PHARMA INCadded+105,000$2.03M
ARGXnew+5,529$1.95M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
ILMNreduced-24,100-$4.6M
MASSexited-20,000-$412K
SINGULAR GENOMICS SYSTEMS INexited-20,000-$76K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2022

Share positions as resolved from 13F-HR 0001104659-22-115855, largest first. % of portfolio is the value over $275,829,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ALPINE IMMUNE SCIENCES INCALPINE IMMUNE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 4,708,288 shares; 2022Q2: 4,708,288 shares; 2022Q3: 6,708,288 shares 6,708,288$48.3M17.51%+2,000,000
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: 1,824,583 shares; 2022Q3: 1,824,583 shares 1,824,583$39.5M14.33%0Timeline
HLTHQCUE HEALTH INC COM (DE)Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 8,980,909 shares; 2022Q2: 8,980,909 shares; 2022Q3: 8,980,909 shares 8,980,909$27M9.8%0Timeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 154,238 shares; 2022Q2: 154,238 shares; 2022Q3: 130,138 shares 130,138$24.8M9%-24,100Timeline
RCUSARCUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 869,790 shares; 2022Q2: 869,790 shares; 2022Q3: 869,790 shares 869,790$22.8M8.25%0Timeline
PROMETHEUS BIOSCIENCES INCPROMETHEUS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 250,000 shares; 2022Q2: 250,000 shares; 2022Q3: 250,000 shares 250,000$14.8M5.35%0
ALBIREO PHARMA INCALBIREO PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 518,342 shares; 2022Q2: 518,342 shares; 2022Q3: 623,342 shares 623,342$12.1M4.38%+105,000
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 303,984 shares; 2022Q2: 303,984 shares; 2022Q3: 359,554 shares 359,554$10.2M3.71%+55,570Timeline
EQEQUILLIUM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 4,447,308 shares; 2022Q2: 4,447,308 shares; 2022Q3: 4,447,308 shares 4,447,308$9.87M3.58%0Timeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 1,463,872 shares; 2022Q2: 1,463,872 shares; 2022Q3: 1,463,872 shares 1,463,872$8.51M3.08%0Timeline
ADICET BIO INCADICET BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 580,000 shares; 2022Q2: 580,000 shares; 2022Q3: 580,000 shares 580,000$8.25M2.99%0
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 526,329 shares; 2022Q2: 526,329 shares; 2022Q3: 526,329 shares 526,329$7.44M2.7%0Timeline
Mersana Therapeutics IncMersana Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 904,268 shares; 2022Q2: 904,268 shares; 2022Q3: 904,268 shares 904,268$6.11M2.22%0
Pyxis Oncology, Inc (former…Pyxis Oncology, Inc (formerly Ape…Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 1,894,551 shares 1,894,551$5.12M1.85%new
BYSIBEYONDSPRING INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 4,958,142 shares; 2022Q2: 4,958,142 shares; 2022Q3: 4,958,143 shares 4,958,143$4.91M1.78%+1Timeline
HORIZON THERAPEUTICS PLCHORIZON THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: 55,400 shares; 2022Q3: 78,900 shares 78,900$4.88M1.77%+23,500
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 714,285 shares; 2022Q2: 714,285 shares; 2022Q3: 714,285 shares 714,285$4.21M1.53%0Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 210,000 shares; 2022Q2: 210,000 shares; 2022Q3: 210,000 shares 210,000$3.81M1.38%0Timeline
SEATTLE GENETICS INCSEATTLE GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 23,014 shares 23,014$3.15M1.14%new
SEMA4 HOLDINGS CORPSEMA4 HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 3,418,929 shares; 2022Q2: 3,418,929 shares; 2022Q3: 3,418,929 shares 3,418,929$3M1.09%0
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: not reported; 2022Q2: not reported; 2022Q3: 5,529 shares 5,529$1.95M0.71%newTimeline
AtriCure Inc.AtriCure Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 46,259 shares; 2022Q2: 46,259 shares; 2022Q3: 46,259 shares 46,259$1.81M0.66%0
SCYXSCYNEXIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 555,555 shares; 2022Q2: 555,555 shares; 2022Q3: 555,555 shares 555,555$1.33M0.48%0Timeline
OWLET INCOWLET INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 898,400 shares; 2022Q2: 898,400 shares; 2022Q3: 898,400 shares 898,400$961K0.35%0
NAUTNAUTILUS BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 300,000 shares; 2022Q2: 300,000 shares; 2022Q3: 300,000 shares 300,000$636K0.23%0Timeline
Ohr Pharmaceutical IncOhr Pharmaceutical IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2020Q4: restricted; 2021Q1: restricted; 2021Q2: restricted; 2021Q3: restricted; 2021Q4: not loaded; 2022Q1: 1,000,000 shares; 2022Q2: 1,000,000 shares; 2022Q3: 1,000,000 shares 1,000,000$395K0.14%0

Sold out in Q3 2022

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MASS908 DEVICES INC20,000$412Kshares
SINGULAR GENOMICS SYSTEMS INSINGULAR GENOMICS SYSTEMS IN20,000$76Kshares

How Q3 2022 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-22-115855 base2022-11-08acceptance time not in the bulk data set